Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy
International Journal of Urology · 2026-11 · 33 (11)
DOI: 10.1111/iju.70693 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Urology, online erschienen am 29.10.2026. Verfasst von Yoichiro Tohi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
ORCID-Profile: Yoichiro Tohi, Mikio Sugimoto
Zitieren
APA
Tohi, Y., & Sugimoto, M. (2026). Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy. International Journal of Urology, 33(11). https://doi.org/10.1111/iju.70693
Vancouver
Tohi Y, Sugimoto M. Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy. International Journal of Urology. 2026;33(11). doi:10.1111/iju.70693
BibTeX
@article{Tohi2026,
author = {Tohi, Yoichiro and Sugimoto, Mikio},
title = {Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy},
journal = {International Journal of Urology},
year = {2026},
volume = {33},
number = {11},
doi = {10.1111/iju.70693}
}
EUVIMED